No abstract available
Grants and funding
Medical writing support was provided by Sara N. Fischer, PhD, CMPP (Citrus Health Group), which was in accordance with Good Publication Practice (GPP 2022) guidelines and funded by AstraZeneca (Cambridge, UK). Drs Xu, Chung, Genofre, and Katial are or were AstraZeneca employees at the time this research was conducted and may hold stock. Ms Schaefer and Dr Szende are or were employees of Labcorp Drug Development (now Fortrea), which received funding from AstraZeneca to perform this research, at the time this research was conducted.